Farmapram (Alprazolam) is a tranquilizer with anxiolytic effect, eliminates fear, anxiety, emotional tension, has moderately expressed antidepressant and hypnotic effects, as well as central myorelaxant activity, which is used for treatment of panic disorder in combination with phobic symptoms. Side effects can occur equally in women and men.
Farmapram is used to treat patients with neurotic and neurosis-like disorders that are accompanied by feelings of anxiety and restlessness. Alprazolam may be prescribed to patients with reactive depressive states, including those developed against the background of somatic diseases.
Alprazolam may be used to treat patients with panic disorders, insomnia, and withdrawal syndrome (including alcohol and drug withdrawal syndrome).
Farmapram (Alprazolam) is not administered to patients with a history of hypersensitivity reactions to the active or additional components of the drug.
Alprazolam tablets are not prescribed for patients with lactose intolerance. Alprazolam is not used for therapy of patients with respiratory insufficiency, manifested renal and hepatic dysfunction, myasthenia, acute glaucoma, and acute alcohol, psychotropic, narcotic or hypnotic drugs poisoning.
Farmapram (Alprazolam) is not used in pediatric practice. Alprazolam should not be administered to patients with alcoholism (during therapy with Alprazolam the use of alcoholic drinks and drugs containing ethyl alcohol is prohibited). During administration of Alprazolam, do not engage in activities that require increased concentration and speed of psychomotor reactions. The use of alprazolam during pregnancy and lactation is prohibited. Before starting therapy with alprazolam in women of childbearing age, pregnancy should be excluded and a reliable contraceptive should be selected. If pregnancy occurs during treatment with alprazolam, a physician should be consulted, who will suggest a scheme of withdrawal of the drug and will assess the possible risks to the fetus.
Combined use of farmapram (alprazolam) with antidepressants in patients with endogenous depression is allowed.
Mutual enhancement of action is noted during concomitant use of alprazolam with neuroleptic agents, hypnotics and anticonvulsants, narcotic analgesics, ethyl alcohol and centrally acting muscle relaxants. When the drug is used in combination with microsomal oxidation inhibitors, the risk of toxic effects of alprazolam increases. There is a decrease in the effectiveness of alprazolam when used in combination with microsomal oxidation inducers. Alprazolam increases imipramine plasma concentrations when used concomitantly.
The description of the drug farmapram (alprazolam) on this page is a simplified and supplemented version of the official instructions for use. Before buying or using the drug, you should consult your physician and read the manufacturer’s approved leaflet. The information about the drug is for information purposes only and must not be used as a guide for self-medication. Only your physician can decide whether to prescribe this medicine and determine the dosage and how to administer it.